Earnings Review
Praj Industries Q1 PAT rises twofold YoY, beats Street view
This story was originally published at 17:42 IST on 13 August 2026
Register to read our real-time news.Informist, Thursday, Aug. 13, 2026
Please click here to read all liners published on this story
--Praj Ind Apr-Jun consol net profit INR 116.07 mln
--Analysts saw Praj Ind Apr-Jun consol net profit at INR 52.80 mln
--Praj Ind Apr-Jun consol revenue INR 7.16 bln
--Analysts saw Praj Ind Apr-Jun consol revenue at INR 6.81 bln
--Praj Ind Apr-Jun consol PAT INR 116.07 mln vs INR 53.39 mln year ago
--Praj Ind Apr-Jun consol revenue INR 7.16 bln vs INR 6.40 bln year ago
--Praj Industries Apr-Jun consol order intake INR 10 bln
By Radhika Tiwari
MUMBAI – Praj Industries Ltd. Thursday reported a twofold increase in its consolidated net profit for the June quarter on the back of healthy growth in revenue, beating analysts' estimates for both top and bottomline.
The biotechnology and engineering company reported a net profit of INR 116.07 million, up 117% from INR 53.39 million in the year-ago quarter. The analysts' estimate for the bottomline was INR 52.80 million. The company reported a consolidated revenue of INR 7.16 billion, up 12% from INR 6.40 billion in the year-ago quarter. The analysts' estimate for the topline was INR 6.81 billion.
The company's other income rose twofold to INR 200 million, up 133% from INR 86 million in the year-ago quarter.
The Pune-based company's total expenses rose 12% on year to INR 7.15 billion. The cost of materials consumed, which constitutes 50% of the total expenses, rose 35% on year to INR 3.61 billion. The company's finance cost fell 27% on year to INR 37.31 million, whereas its depreciation and amortisation expense remained flat at INR 253 million. Order intake during the June quarter was INR 10 billion.
"While the external business environment remained uncertain, we have made a definite progress on few long-term growth vectors," Ashish Gaikwad, managing director of the company, said in a press release. "Key developments this quarter include securing a Bio-IBA (indole-3-butyric acid) order for the country's first commercial scale demo plant, signing a long-term framework agreement for precision fabrication and modularization solutions for hyperscale data centers, and receiving first order from a leading semiconductor player for ultra-pure water and ZLD (zero liquid discharge) solutions."
"Union cabinet approves GOBARdhan scheme with a total outlay of 23,731 crore (INR 237.31 billion); to accelerate CBG production through assured offtake, stable pricing, capital assistance, pipeline connectivity and access to finance," the company said in a press release.
Thursday, the company's shares closed at INR 321.55 on the National Stock Exchange, down nearly 1% from Wednesday. The company announced its June quarter earnings during market hours. End
Edited by Avishek Dutta
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe


